Stefan Kraiss

458 citations
9 papers · 392 indexed · h-index 6
Topics
Cancer-related Molecular Pathways (6 papers)Virus-based gene therapy research (3 papers)Cancer Research and Treatments (3 papers)
Partner nations
Germany

In The Last Decade

Stefan Kraiss

9 papers receiving 378 citations

Peers

Stefan Kraiss
Comparison fields: 5 of 44
  • Oncology 318
  • Molecular Biology 236
  • Biotechnology 94
  • Cancer Research 59
  • Genetics 57
Replace May P with:
May P France
H W Stürzbecher United Kingdom
Betsy H. Mims United States
Suzanne K. Chandler United States
Michael Quintanilla United States
Satoko Inoda Japan
Robin S. Quartin United States
Josephine Walton United Kingdom
Desmond Roche Ireland
Jane Ramsdale United Kingdom
Stefan Kraiss relative to May P France May P's profile →
Citations per field
00.5×
May P · 1×
Citations per year

Countries citing papers authored by Stefan Kraiss

Since Specialization
Citations

This map shows the geographic impact of Stefan Kraiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Kraiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Kraiss more than expected).

Fields of papers citing papers by Stefan Kraiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Kraiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Kraiss. The network helps show where Stefan Kraiss may publish in the future.

Co-authorship network of co-authors of Stefan Kraiss

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Kraiss. A scholar is included among the top collaborators of Stefan Kraiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Kraiss. Stefan Kraiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 2
2 10
3 51
4
Association of casein kinase II with immunopurified p53.
71
5 3
6
Protein kinase activity associated with immunopurified p53 protein.
21
7
Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
96
8 137
9 1

About Stefan Kraiss

Stefan Kraiss is a scholar working on Biotechnology, Oncology and Genetics, having authored 9 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Virus-based gene therapy research (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (318 citations), Biotechnology (94 citations) and Cancer Research (59 citations). Stefan Kraiss has collaborated with scholars based in Germany. Frequent co-authors include Mathias Montenarh, Moshe Oren, Andrea Quaiser, Mark Kohler, Angelika Barnekow, Andreas Lorenz, Wolfgang Hartmann and U. Vetter. Their work appears in journals such as Journal of Virology, Experimental Cell Research and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026